Specific therapy in Parkinson's disease.
D000547:Amantadine / Q000008:administration & dosage*; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D004295:Dihydroxyphenylalanine; D000547:Amantadine